^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
ThyGeNEXT® + ThyraMIR®

Type:
Laboratory Developed Test
Related tests:

Details

Evidence
ThyGeNEXT® + ThyraMIR®v2 provides mutational analysis, microRNA algorithmic classification, and microRNA pairwise expression profiling. The test analyzes microRNA signatures to improve risk assessment of indeterminate thyroid nodules.
Cancer:
Thyroid Gland Carcinoma, Thyroid Gland Papillary Carcinoma
Gene:
ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), GNAS (GNAS Complex Locus), HRAS (Harvey rat sarcoma viral oncogene homolog), KRAS (KRAS proto-oncogene GTPase), NRAS (Neuroblastoma RAS viral oncogene homolog)
See More ...
Method:
Next-Generation Sequencing (NGS)